- Advert number: 307036-0
- Posted Date: 02/07/12
- Closing Date: 11/08/12
UNIVERSITY OF BIRMINGHAM
Endocrinology and Diabetes
College of Medical and Dental Sciences
School of Clinical and Experimental Medicine
Salary from £30,992 to £53,663 a year
Applications are invited for a Clinical Lecturer in Endocrinology and Diabetes based in the School of Clinical and Experimental Medicine. The post is linked to the Centre for Endocrinology, Diabetes and Metabolism (CEDAM), underpinning major international and world-leading research excellence in translational endocrinology, steroid hormone action, obesity and metabolism, diabetes and autoimmunity, and endocrine cancer.
The successful applicant will be an academic endocrine trainee with appropriate clinical and research profile and the potential to pursue a successful academic career as indicated by a higher academic degree and original research publications. The post holder will be expected to contribute significantly to the established research and education programmes of the School and Centre. The post attracts academic specialist trainee status (academic NTN), with the clinical components of training as part of the West Midlands endocrinology and diabetes speciality programme being delivered in rotation across the New Queen Elizabeth Hospital, University Hospital Birmingham (UHB), NHS Foundation Trust, and Birmingham Heartland’s Hospital, part of Heart of England NHS Foundation Trust.
Informal enquiries can be made to: Professor Jayne Franklyn, Head of School, email@example.com
Professor Wiebke Arlt, Head of CEDAM, firstname.lastname@example.org
For clinical service aspects of the post, enquiries can be made to Dr Sailesh Sankar, Chairman of the West Midlands Higher Speciality Training Committee for Endocrinology and Diabetes, email: email@example.com
Closing date: 11th August 2012.
To download the details and submit an electronic application online visit: www.hr.bham.ac.uk/jobs alternatively information can be obtained from 0121 415 9000.
VALUING EXCELLENCE; SUSTAINING INVESTMENT.